Burshtein Gregory
SEC insider (Form 3/4/5 filer). CIK 0002026002. Chief of R&D at Entera Bio Ltd. (ENTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in JERUSALEM.
Companies Burshtein Gregory has filed insider reports for
- Entera Bio Ltd. (ENTX): Officer, Chief of R&D
Burshtein Gregory
CIK: 0002026002
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ENTX
Entera Bio Ltd.
Officer